What is the immediate management for a patient with a history of diabetes presenting with a hyperglycemic crisis, potentially complicated by diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar nonketotic syndrome (HHNS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Hyperglycemic Crisis

A patient with diabetes presenting in hyperglycemic crisis requires immediate intravenous fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr, followed by continuous IV insulin infusion at 0.1 units/kg/hr after initial fluid bolus, with aggressive potassium monitoring and replacement to prevent life-threatening complications. 1, 2

Initial Assessment and Diagnostic Confirmation

Rapidly assess for DKA versus HHS by checking blood glucose, arterial or venous pH, bicarbonate, and ketones (preferably β-hydroxybutyrate in blood rather than urine ketones). 1, 2

  • DKA criteria: Blood glucose >250 mg/dL, arterial pH <7.3, bicarbonate <15 mEq/L, and moderate ketonemia or ketonuria 1
  • HHS presentation: More gradual onset over days to a week with severe dehydration, altered mental status, and extreme hyperglycemia (often >600 mg/dL) but minimal ketosis 3, 4
  • The combination of vomiting with ketosis strongly indicates DKA requiring immediate intervention 1, 3

Identify precipitating factors immediately: infection (most common), medication non-adherence, new-onset diabetes, myocardial infarction, or stroke. 1, 5

Step 1: Aggressive Fluid Resuscitation (FIRST PRIORITY)

Begin isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr during the first hour to restore circulatory volume and tissue perfusion. 1, 2

  • After the first hour, continue at 4-14 mL/kg/hr based on hemodynamic status 1
  • Dehydration is a critical factor that increases hospitalization risk and mortality 6
  • Critical pitfall: Do not delay fluid resuscitation while waiting for laboratory results 4

Step 2: Insulin Therapy (After Initial Fluid Bolus)

Start continuous IV regular insulin at 0.1 units/kg/hr after fluid resuscitation has begun. 1, 2, 7

  • If glucose does not fall by 50-75 mg/dL in the first hour, double the insulin infusion rate 1
  • Once blood glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion to prevent hypoglycemia and allow continued clearance of ketones 1
  • Critical pitfall: Never discontinue IV insulin prematurely—continue until ketones clear, not just until glucose normalizes 1, 4

Step 3: Potassium Management (ESSENTIAL)

Monitor serum potassium every 2-4 hours as insulin therapy drives potassium intracellularly, causing potentially fatal hypokalemia. 1, 7

  • Begin potassium replacement when serum levels fall below 5.2 mEq/L, provided adequate urine output is present 1
  • Typical replacement is 20-30 mEq per liter of IV fluid 1
  • Critical warning: Untreated hypokalemia can cause respiratory paralysis, ventricular arrhythmia, and death 7

Ongoing Monitoring Requirements

Check blood glucose every 1-2 hours until stable and monitor electrolytes, BUN, creatinine, and venous pH every 2-4 hours. 1, 2

  • Assess for cerebral edema (especially in children and adolescents): headache, altered mental status, seizures, bradycardia 1
  • Monitor for signs of treatment complications including hypoglycemia and hypokalemia 7, 4

Transition to Subcutaneous Insulin

Administer subcutaneous basal insulin 2-4 hours BEFORE discontinuing IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis. 1, 2

  • Critical pitfall: Premature termination of IV insulin or insufficient overlap with subcutaneous insulin is a common management error that leads to recurrence 4
  • Target pre-meal glucose <140 mg/dL and random glucose <180 mg/dL for non-critically ill patients 2

Special Populations Requiring Modified Approach

Pregnant patients: Any concern for DKA requires immediate medical attention due to significant feto-maternal harm risk; may present with euglycemic DKA (glucose <200 mg/dL). 3

SGLT2 inhibitor users: Can develop euglycemic DKA with normal or near-normal glucose levels, requiring the same urgent management despite lower glucose readings. 1, 3

Children: Higher risk of cerebral edema during treatment, requiring closer monitoring during fluid resuscitation. 3

Critical Management Pitfalls to Avoid

  • Never discontinue insulin during illness, even if the patient is not eating—this precipitates DKA 6, 3
  • Do not stop IV insulin when glucose normalizes; continue until ketones clear 1, 4
  • Do not forget potassium replacement—insulin therapy without potassium monitoring is dangerous 1, 7
  • Ensure adequate overlap between IV and subcutaneous insulin (2-4 hours) 1, 2, 4

Treatment of Underlying Precipitating Factors

Identify and aggressively treat infection or other stressors that triggered the crisis. 6, 1

  • Aggressive glycemic management with insulin may reduce morbidity in severe acute illness 6
  • A physician with expertise in diabetes management should oversee hospitalized patient care 6

Prevention of Recurrence

Review sick-day management: Never discontinue insulin during illness, monitor blood glucose and ketones when glucose >200-300 mg/dL, seek professional advice early. 1, 3

  • Educate on when to check ketones: glucose >200 mg/dL, illness symptoms (nausea, vomiting, abdominal pain), missed insulin doses, or unexplained hyperglycemia 3
  • Blood ketone testing is preferred over urine testing for more accurate real-time assessment 3

References

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia and Ataxia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of hyperglycemic emergencies.

Hormones (Athens, Greece), 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate use of dextrose (glucose) in a hyperosmolar state, such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)?
What is the difference between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)?
What is the management for a patient with severe hyperglycemia (elevated blood glucose)?
What should be the aim in managing hyperglycemia in a diabetic ketoacidosis (DKA) patient?
How to manage a 60-year-old male with acute limb ischemia, acute myocardial infarction (MI), hyperglycemia (RBS 456), ketonuria, and metabolic acidosis (pH 7.461, HCO3 10.7, pCO2 14.8) with hyponatremia (Na 127.1) and hypochloremia (Cl 101.8)?
What antibiotics can be used to treat an adult patient with no significant medical history and an inflamed pilonidal cyst who cannot undergo surgery for months?
Can an elderly patient with neck pain and a contraindication to oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) use Voltaren gel (Diclofenac)
What are the precautions for prescribing Trazodone (antidepressant) to older adults with a history of heart conditions due to the risk of QT (QT interval) prolongation?
What is the treatment for a patient with urticarial vasculitis, possibly with a history of autoimmune disorders such as lupus or rheumatoid arthritis?
What are the best practices for performing a Lower Segment Caesarean Section (LSCS) on a pregnant woman, particularly one with potential underlying medical conditions such as hypertension or diabetes?
What is the recommended management for a young adult female with Low-grade Squamous Intraepithelial Lesions (LSIL), Human Papillomavirus (HPV) positive, and Cervical Intraepithelial Neoplasia grade 1 (CIN 1)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.